Form 8-K Mast Therapeutics, Inc. For: Nov 12

Go back to Form 8-K Mast Therapeutics, Inc. For: Nov 12

Mast Therapeutics (MSTX) Reports In-Line Q3 EPS

November 12, 2015 4:28 PM EST

Mast Therapeutics (NYSE: MSTX) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06).

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

... More